- Did you mean
- outcome
Search results - 9 results
Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI)
and quantitative outcomes of B1MG MLM assessment in Belgium and discuss their relevance to GDI. The insights gained from this study can be helpful for steering future policy directions and interventions ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
screening population. The primary outcome will be to assess the diagnostic test accuracy of host and HPV DNA methylation for high-grade CIN; the secondary outcomes will be to examine the accuracy of different ...
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.
public health, the performance characteristics of assays should be evaluated to ensure reliable diagnostic outcomes are achieved. METHODS: VALCOR or “ VAL idation of SARS- COR ona Virus-2 assays” is ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
impact on findings then evaluations with more realistic assumptions will be conducted. Promising strategies will be investigated further by multi-cohort simulations predicting health outcomes, resource use ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
the nonavalent vaccine were excluded since women in the control group received the quadrivalent vaccine. Main efficacy outcomes were: histologically confirmed cervical precancer lesions distinguishing ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
antibodies against the vaccine HPV types). We will assess clinical effectiveness by evaluating outcomes in all women, irrespective of the HPV DNA or serology status at enrolment. Evaluation by fine age and ...
CanCon European Guide on Quality Improvement in Comprehensive Cancer Control- Chapter 4: Screening
here are currently lacking in many European settings, which may contribute substantially to inequalities in cancer prevention outcomes observed both between and within countries. Organization for the ...
Thematic Working Group 5: Personalized Medicine
medicine Abstract: This document summarizes the outcome of the discussions within the thematic working group during the period June 2013 — Octobre 2014. There was decided on a common basis of understanding ...